Muffy Carter

Consigliere Generale presso ALBIREO PHARMA, INC.

71 anni

Health Technology

Consumer Services

Commercial Services

Profilo

Martha J.
Carter currently works at Albireo Pharma, Inc., as Chief Regulatory Officer from 2016.
Ms. Carter also formerly worked at Regulatory Affairs Professionals Society, as Director in 1999, Genetics Institute LLC, as Principal, ImmuLogic Pharmaceutical Corp., as Principal, GelTex Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 1998 to 2002, Proteon Therapeutics, Inc., as Chief Regulatory Officer in 2011, Aegerion Pharmaceuticals, Inc., as Chief Regulatory Officer from 2011 to 2016, Fisons Plc, as Principal, Trine Pharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs from 2002 to 2008, and EMD Serono, Inc., as Principal.
Ms. Carter received her undergraduate degree from Northeastern University.

Posizioni attive di Muffy Carter

Società	Posizione	Inizio
ALBIREO PHARMA, INC.	Consigliere Generale	29/11/2016

Tutte le posizioni attive di Muffy Carter

Precedenti posizioni note di Muffy Carter

Società	Posizione	Fine
AEGERION PHARMACEUTICALS, INC.	Consigliere Generale	20/07/2016
PROTARA THERAPEUTICS, INC.	Consigliere Generale	01/02/2011
Trine Pharmaceuticals, Inc. Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA.	Consigliere Generale	19/09/2008
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.	Consigliere Generale	01/01/2002
Regulatory Affairs Professionals Society Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD.	Direttore/Membro del Consiglio	01/01/1999

Vedi nel dettaglio l'esperienza di Muffy Carter

Formazione di Muffy Carter

Northeastern University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Muffy Carter

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	10
Trine Pharmaceuticals, Inc. Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA.	Health Technology
Proteon Therapeutics, Inc. Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.	Health Technology
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.	Health Technology
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.	Health Technology
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	Health Technology
Fisons Plc Fisons Plc Pharmaceuticals: OtherHealth Technology Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom.	Health Technology
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Health Technology
Regulatory Affairs Professionals Society Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD.	Commercial Services
Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA.	Health Technology
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.	Health Technology